In this issue:
PH symptom severity and its effect on health-related QOL over time
Choice of initial oral therapy for PAH
Features and outcomes of methamphetamine-associated PAH
Subcutaneous treprostinil for severe nonoperable CTEPH
Risk assessment in medically treated CTEPH
Adjunctive intermittent pneumatic compression for venous thromboprophylaxis
Overtreatment and treatment-related adverse effects in subsegmental PE
Rivaroxaban for thromboprophylaxis in high-risk ambulatory cancer patients
Apixaban to prevent VTE in cancer Inhaled tranexamic acid for haemoptysis
Please login below to download this issue (PDF)